5461 - 5470 of 7916 Results
Title
Year
-
RESTRICTEDTitle: The Therapeutic Potential of Metformin in Neurodegenerative DiseasesJournal Name: Frontiers in EndocrinologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fendo.2018.00400Best OA location URL: https://www.frontiersin.org/articles/10.3389/fendo.2018.00400/pdfCitation Count: 209
-
RESTRICTEDTitle: A new model to study cell-to-cell transfer of αSynuclein in vivoJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 503Issue #: 3Start Page: 1385End Page: 1393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2018.07.053Citation Count: 8
- NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease2018OPENTitle: NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0061-5Best OA location URL: https://www.nature.com/articles/s41531-018-0061-5.pdfCitation Count: 134
- The GBA p.Trp378Gly mutation is a probable French‐Canadian founder mutation causing Gaucher disease and synucleinopathies2018OPENTitle: The GBA p.Trp378Gly mutation is a probable French‐Canadian founder mutation causing Gaucher disease and synucleinopathiesJournal Name: Clinical GeneticsPublisher: WileyVol: 94Issue #: 3-4Start Page: 339End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/cge.13405Best OA location URL: https://zenodo.org/record/3911322Citation Count: 9
- Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis2018OPENTitle: Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosisJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 27Issue #: 21Start Page: 3761End Page: 3771Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddy260Best OA location URL: https://academic.oup.com/hmg/article-pdf/27/21/3761/26127115/ddy260.pdfCitation Count: 50
-
RESTRICTEDTitle: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart ReviewJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 41Issue #: 5Start Page: 156End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296Citation Count: 11
-
OPENTitle: The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 308Issue #:Start Page: 111End Page: 119Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404626Citation Count: 36
- Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease2018OPENTitle: Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2018.00560Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2018.00560/pdfCitation Count: 51
- MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients2018RESTRICTEDTitle: MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease PatientsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 3Start Page: 2092End Page: 2100Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1219-1Citation Count: 17
- Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning2018OPENTitle: Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-28840-wBest OA location URL: https://www.nature.com/articles/s41598-018-28840-w.pdfCitation Count: 46